Shares of Utah Medical Products, Inc. (NASDAQ:UTMD – Get Free Report) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $66.86 and traded as high as $71.53. Utah Medical Products shares last traded at $69.33, with a volume of 10,441 shares traded.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Utah Medical Products in a research report on Friday, May 22nd. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, Utah Medical Products presently has an average rating of “Hold”.
View Our Latest Research Report on Utah Medical Products
Utah Medical Products Stock Performance
Utah Medical Products (NASDAQ:UTMD – Get Free Report) last released its quarterly earnings results on Thursday, April 23rd. The medical instruments supplier reported $0.82 earnings per share for the quarter. The firm had revenue of $8.72 million during the quarter. Utah Medical Products had a return on equity of 9.13% and a net margin of 28.90%.
Utah Medical Products Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, July 3rd. Investors of record on Wednesday, June 17th were issued a dividend of $0.31 per share. The ex-dividend date was Wednesday, June 17th. This represents a $1.24 annualized dividend and a yield of 1.8%. Utah Medical Products’s dividend payout ratio is presently 36.69%.
Institutional Investors Weigh In On Utah Medical Products
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Brandes Investment Partners LP raised its stake in Utah Medical Products by 4.0% in the 4th quarter. Brandes Investment Partners LP now owns 351,322 shares of the medical instruments supplier’s stock worth $19,660,000 after purchasing an additional 13,392 shares in the last quarter. Quantinno Capital Management LP bought a new position in shares of Utah Medical Products during the second quarter worth approximately $608,000. Segall Bryant & Hamill LLC increased its holdings in shares of Utah Medical Products by 87.7% during the first quarter. Segall Bryant & Hamill LLC now owns 21,547 shares of the medical instruments supplier’s stock worth $1,336,000 after purchasing an additional 10,065 shares during the period. Ritholtz Wealth Management raised its position in shares of Utah Medical Products by 168.5% in the first quarter. Ritholtz Wealth Management now owns 14,807 shares of the medical instruments supplier’s stock valued at $918,000 after buying an additional 9,293 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of Utah Medical Products by 6.5% in the second quarter. Geode Capital Management LLC now owns 114,816 shares of the medical instruments supplier’s stock valued at $6,537,000 after buying an additional 7,040 shares during the period. 69.60% of the stock is currently owned by institutional investors and hedge funds.
About Utah Medical Products
Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.
The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).
Featured Stories
- Five stocks we like better than Utah Medical Products
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.
